Detection of Aβ plaque deposition in MR images based on pixel feature selection and class information in image level
暂无分享,去创建一个
Fan Li | Yongming Li | Jie Wang | Pin Wang | Mingguo Qiu | Shujun Liu | Xueru Zhu
[1] Ryan Chamberlain,et al. Comparison of amyloid plaque contrast generated by T2‐weighted, T 2* ‐weighted, and susceptibility‐weighted imaging methods in transgenic mouse models of Alzheimer's disease , 2009, Magnetic resonance in medicine.
[2] Rui Liu,et al. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease , 2011, Behavioural Brain Research.
[3] Thomas Beyer,et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] Keith A. Johnson,et al. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging , 2013, Alzheimer's & Dementia.
[5] Andrew King,et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. , 2009, Acta neuropathologica.
[6] Philip Scheltens,et al. Validation of soluble amyloid‐β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases , 2016, Journal of neurochemistry.
[7] David A Bennett,et al. Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With A&bgr; Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue , 2012, Alzheimer disease and associated disorders.
[8] Ulas Bagci,et al. A review on segmentation of positron emission tomography images , 2014, Comput. Biol. Medicine.
[9] Juan Manuel Górriz,et al. Principal component analysis-based techniques and supervised classification schemes for the early detection of Alzheimer's disease , 2011, Neurocomputing.
[10] Andrea Chincarini,et al. Medial temporal lobe high resolution magnetic resonance images for the early diagnosis of Alzheimer's disease , 2015, 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[11] Sascha Weggen,et al. Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X , 2015, Scientific Reports.
[12] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[13] C. Jack,et al. Boosting power for clinical trials using classifiers based on multiple biomarkers , 2010, Neurobiology of Aging.
[14] P. Thompson,et al. PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.
[15] Kaj Blennow,et al. β-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease , 2002, Peptides.
[16] Edward S. Yang,et al. P4-007 High field MRI study of the beta amyloid and plaque deposits in the brain of APP/PS1 mice , 2006, Alzheimer's & Dementia.
[17] Yong Fan,et al. Detection of Alzheimer's disease using group lasso SVM-based region selection , 2015, Medical Imaging.
[18] S. Ramakrishnan,et al. Diffusion Tensor Based Alzheimer Image Analysis Using Region Specific Volume Features and Random Forest Classifier , 2014 .
[19] Yongming Li,et al. Two coding based adaptive parallel co-genetic algorithm with double agents structure , 2010, Eng. Appl. Artif. Intell..
[20] Chokri Ben Amar,et al. Alzheimer's disease diagnosis on structural MR images using circular harmonic functions descriptors on hippocampus and posterior cingulate cortex , 2015, Comput. Medical Imaging Graph..
[21] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[22] H. Lester,et al. Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease , 2005, PLoS medicine.
[23] Qing X Yang,et al. MRI and histological analysis of beta‐amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice , 2009, Journal of magnetic resonance imaging : JMRI.